Live News Categoriesequity

Alar Pharmaceuticals Inc. (6785.TWO) News

Follow Alar Pharmaceuticals Inc. (6785.TWO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 6785.TWO Asset equity Sector Markets 90 days 1 Last 85.7 Updated Oct 16, 2026, 07:57 AM UTC Open live news feed

L BRIEF — Alar Submits Application To US FDA For Clinical Trial Of ALA — 3000 For Depression Oct 16 (Reuters) — Alar Pharmaceuticals Inc: Submits Application To Us Fda For Phase Ii Clinical Trial Of Ala-3000 For Depression Treatment Source text:... Further company coverage: (Reporting by Hong Kong newsroom) ((do REGULATION | Oct 16, 2026, 07:57 AM UTC